E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋
含有
性抗原表位,能诱导机体产生
性抗体。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋
含有
性抗原表位,能诱导机体产生
性抗体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对存在于耐受原上的免疫原性表位的特异性免疫耐受。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高
E2蛋白含有中和性抗原表位,能诱导机体产生中和性抗体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对存在于耐受原上免疫原性表位
特异性免疫耐受。
声明:以上句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋白含有中和性抗原表位,能
体产生中和性抗体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对存在于耐受原上的免疫原性表位的特异性免疫耐受。
声明:以上例句、词性分均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋白含有中和性
表
,能诱导机体产生中和性
体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
致耐受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对
耐受
上的免疫
性表
的特异性免疫耐受。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋白含有中和性
表位,能诱导机体产生中和性
体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对存
于
受
上的免疫
性表位的特异性免疫
受。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋白含有
表位,能诱导机体产生
体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对存在于耐受上的免疫
表位的特异
免疫耐受。
声明:以上例句、词分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋白含有中和性抗原表位,能诱导机体产生中和性抗体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐后,将免疫抑制剂从宿主撤离,宿主仍能保持对存在于耐
原上的免疫原性表位的特异性免疫耐
。
声明:以上例句、词性分类均由互网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
区的E2蛋白含有中和性抗原表位,能诱导机体产生中和性抗体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐受方案后,将免疫抑制剂从宿主撤离,宿主仍能保持对存在于耐受原上的免疫原性表位的特异性免疫耐受。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
E2 protein, including hypervariable region 1 (HVR1) in the N-terminal region, contains some epitopes that can induce neutralizing antibodies.
括高变区的E2蛋白含有中和性抗
表位,能诱导机体产生中和性抗体。
After the tolerizing regimen, the host is withdrawn from the suppressive agents, but is able to maintain specific immune tolerance to the immunogenic epitopes present on the toleragen.
在致耐受方案后,将抑制剂从宿主撤离,宿主仍能保持对存在于耐受
上的
性表位的特异性
耐受。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。